Indorama Ventures Performance degli utili passati
Criteri Il passato verificati 0/6
Gli utili di Indorama Ventures sono diminuiti a un tasso medio annuo di -53.2%, mentre il settore Chemicals ha visto gli utili crescere a un tasso medio annuo di 5%. I ricavi sono cresciuti crescere a un tasso medio annuo di 1.1%.
Informazioni chiave
-53.18%
Tasso di crescita degli utili
-53.18%
Tasso di crescita dell'EPS
| Chemicals Crescita del settore | 8.05% |
| Tasso di crescita dei ricavi | 1.06% |
| Rendimento del capitale proprio | -5.98% |
| Margine netto | -2.21% |
| Ultimo aggiornamento sugli utili | 31 Mar 2026 |
Aggiornamenti sulle prestazioni recenti
Recent updates
IVL: Lower Discount Rate And Higher Future P/E Will Support Upside
Analysts have raised their price target on Indorama Ventures from THB 28.0 to THB 31.1 as they update their views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Board meeting scheduled for February 27, 2026 to consider convening the Annual General Meeting of Shareholders, which can shape upcoming decisions on dividends, capital allocation, and governance (Key Developments).
IVL: Higher Future P/E Assumptions Will Constrain Share Price Upside
Analysts have raised their price target for Indorama Ventures from THB17.54 to THB21.00, citing updated assumptions on the discount rate, revenue trajectory, profit margin, and future P/E multiples as key drivers of the change. What's in the News Board meeting scheduled for Feb 27, 2026, to consider convening the Annual General Meeting of Shareholders, which may shed light on upcoming resolutions and corporate priorities (Key Developments).IVL: Higher Assumed P/E And Softer Margins Will Restrain Future Returns
Analysts now set their price target for Indorama Ventures at about THB17.54, compared with the prior fair value estimate of about THB14.82. This reflects updated views on a lower discount rate, a smaller expected revenue decline, slightly softer profit margins, and a higher assumed future P/E multiple.
IVL: Green Chemistry And AI Will Shape Balanced Prospects Into 2026
Indorama Ventures' analyst price target has been adjusted slightly to THB 23.07 from THB 23.03, with analysts pointing to updated assumptions that include a different discount rate, higher modeled revenue growth, a lower profit margin, and a higher future P/E multiple. What's in the News Board meeting scheduled for Feb 27, 2026, with the agenda to consider convening the Annual General Meeting of Shareholders (Key Developments).IVL: Lower Discount Rate And Higher Future P/E Will Support Upside
Analysts have nudged their fair value estimate for Indorama Ventures slightly lower from THB 28.10 to THB 28.00, reflecting updated views around a reduced discount rate, higher assumed revenue growth, a slimmer profit margin, and a higher future P/E multiple. What's in the News Board meeting scheduled for Feb 27, 2026 to consider convening the Annual General Meeting of Shareholders, which can set the timetable for key shareholder decisions (Key Developments).IVL: Green Chemistry And AI Will Support Measured Future Return Potential
Analysts have trimmed their 12 month price target for Indorama Ventures slightly to THB23.03 from THB23.39, reflecting refreshed assumptions around the discount rate, revenue growth, profit margin and future P/E that point to only modest tweaks in their valuation views. What's in the News Indorama Ventures held an Analyst/Investor Day, which gave the market an opportunity to hear updated views and priorities directly from management (Key Developments).IVL: Lower Future P/E Multiple Will Limit Share Price Upside
Analysts have trimmed their price target for Indorama Ventures to approximately US$14.82 from about US$15.30, citing updated assumptions around discount rates, slightly different revenue expectations, improved profit margin forecasts, and a lower future P/E multiple. Valuation Changes Fair Value: Trimmed slightly from US$15.30 to about US$14.82 per share.IVL: Green Chemistry And AI Will Support Future Upside Potential
Analysts have slightly reduced their price target for Indorama Ventures to US$23.39 from about US$23.54, reflecting updated assumptions for more moderate revenue growth, a marginally lower profit margin outlook, and a slightly higher future P/E multiple, while keeping the discount rate unchanged. Valuation Changes Fair Value: reduced slightly from US$23.54 to US$23.39 per share.IVL: Stronger Margins And Lower P/E Will Support Upside Potential
Analysts have trimmed their price target for Indorama Ventures to $28.10, reflecting slightly softer revenue growth assumptions, together with a modestly higher profit margin outlook and a lower forward P/E multiple. Valuation Changes Fair Value: Unchanged at THB 28.10 per share, indicating no adjustment to the overall valuation anchor.IVL: Sustainability Breakthroughs In Fragrance Solubilization Will Support Stronger Profit Margins
Analysts have modestly reduced their price target for Indorama Ventures from THB 29.0 to THB 28.1, citing a higher required discount rate despite stronger expectations for revenue growth and profit margins in the future. What's in the News Indorama Ventures unit Indovinya launched an Open Innovation Challenge targeting sustainable fragrance solubilization solutions for the personal care market, in partnership with AEVO (Key Developments).IVL: Higher Required Returns And Lower Margins Will Temper Future Upside
Analysts have trimmed their fair value estimate for Indorama Ventures from about $18.00 to roughly $15.30 per share. They cite a higher required discount rate, weaker expected profit margins, and a richer future earnings multiple that together temper the upside case despite slightly improved revenue trends.IVL: Green Chemistry and AI Solutions Will Accelerate Market Leadership
Analysts have revised their price target for Indorama Ventures slightly downward from $24.18 to $23.54. This change is based on updated expectations for revenue growth and profit margins.IVL: Sustainable Solutions Drive Renewed Confidence Amid Market Opportunity
Analysts have lowered their price target for Indorama Ventures from $24.64 to $24.18. They cited revised growth assumptions and a slightly higher discount rate in their updated models.
Indovinya And Indovida IPOs Plus PET Recycling Expansion To Boost Profits And Margins
Asset rationalization and restructuring initiatives aim to improve profitability by reducing costs and boosting operational efficiency.Ripartizione dei ricavi e delle spese
Come Indorama Ventures guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storico di utili e ricavi
| Data | Ricavi | Utili | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 31 Mar 26 | 441,801 | -9,768 | 50,624 | 0 |
| 31 Dec 25 | 451,196 | -8,263 | 50,936 | 0 |
| 30 Sep 25 | 469,758 | -2,660 | 49,320 | 0 |
| 30 Jun 25 | 496,880 | -516 | 51,059 | 0 |
| 31 Mar 25 | 526,014 | -22,947 | 60,736 | 0 |
| 31 Dec 24 | 544,095 | -20,465 | 62,327 | 0 |
| 30 Sep 24 | 551,098 | -33,758 | 64,525 | 0 |
| 30 Jun 24 | 552,450 | -34,847 | 64,827 | 0 |
| 31 Mar 24 | 543,155 | -11,438 | 59,290 | 0 |
| 31 Dec 23 | 543,627 | -11,548 | 58,737 | 0 |
| 30 Sep 23 | 561,228 | -10,599 | 57,711 | 0 |
| 30 Jun 23 | 600,913 | -2,657 | 59,823 | 0 |
| 31 Mar 23 | 650,887 | 17,210 | 63,067 | 0 |
| 31 Dec 22 | 660,378 | 30,256 | 62,936 | 0 |
| 30 Sep 22 | 648,360 | 47,126 | 61,648 | 0 |
| 30 Jun 22 | 596,117 | 45,537 | 57,016 | 0 |
| 31 Mar 22 | 519,408 | 33,595 | 50,422 | 0 |
| 31 Dec 21 | 470,555 | 25,538 | 47,137 | 0 |
| 30 Sep 21 | 421,682 | 21,603 | 44,235 | 0 |
| 30 Jun 21 | 375,854 | 15,435 | 41,881 | 0 |
| 31 Mar 21 | 339,531 | 7,102 | 38,887 | 0 |
| 31 Dec 20 | 333,602 | 1,665 | 38,378 | 0 |
| 30 Sep 20 | 327,950 | -1,310 | 36,613 | 0 |
| 30 Jun 20 | 331,111 | -973 | 35,160 | 0 |
| 31 Mar 20 | 350,929 | 1,213 | 35,821 | 0 |
| 31 Dec 19 | 354,672 | 4,275 | 34,181 | 0 |
| 30 Sep 19 | 368,047 | 8,072 | 33,430 | 0 |
| 30 Jun 19 | 379,665 | 17,334 | 32,587 | 0 |
| 31 Mar 19 | 368,174 | 23,309 | 30,566 | 0 |
| 31 Dec 18 | 348,255 | 25,415 | 28,318 | 0 |
| 30 Sep 18 | 327,382 | 33,064 | 27,175 | 0 |
| 30 Jun 18 | 303,907 | 26,526 | 27,597 | 0 |
| 31 Mar 18 | 291,919 | 21,220 | 26,316 | 0 |
| 31 Dec 17 | 287,335 | 19,833 | 25,799 | 0 |
| 30 Sep 17 | 281,315 | 12,790 | 24,962 | 0 |
| 30 Jun 17 | 274,508 | 12,458 | 22,564 | 0 |
| 31 Mar 17 | 269,508 | 15,472 | 22,711 | 0 |
| 31 Dec 16 | 255,130 | 15,147 | 21,772 | 0 |
| 30 Sep 16 | 247,350 | 12,332 | 21,450 | 0 |
| 30 Jun 16 | 243,995 | 9,680 | 20,927 | 0 |
| 31 Mar 16 | 238,839 | 9,199 | 19,841 | 0 |
| 31 Dec 15 | 235,284 | 5,559 | 19,168 | 0 |
| 30 Sep 15 | 232,822 | 4,772 | 18,243 | 0 |
| 30 Jun 15 | 233,826 | 5,092 | 17,555 | 0 |
Guadagni di qualità: IVL al momento non è redditizia.
Margine di profitto in crescita: IVL al momento non è redditizia.
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: IVL non è redditizia e le perdite sono aumentate negli ultimi 5 anni a un tasso pari a 53.2% all'anno.
Accelerare la crescita: Impossibile confrontare la crescita degli utili di IVL nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia
Guadagni vs Settore: IVL non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Chemicals ( 14.3% ).
Rendimento del capitale proprio
ROE elevato: IVL ha un Return on Equity negativo ( -5.98% ), in quanto al momento non è redditizio.
Rendimento delle attività
Rendimento del capitale investito
Scoprire le aziende con forti performance passate
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/21 19:22 |
| Prezzo dell'azione a fine giornata | 2026/05/21 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Indorama Ventures Public Company Limited è coperta da 21 analisti. 14 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Komsun Suksumrun | BofA Global Research |
| Suppata Srisuk | Bualuang Securities PCL |
| Amornrat Cheevavichawalkul | CGS International |